用抗白细胞介素-2受体抗体（BT563）治疗异基因骨髓移植后类固醇难治性急性移植物抗宿主病。 - Suppr | 超能文献

Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).

作者信息

Hertenstein B, Stefanic M, Sandherr M, Bunjes D, Mertens T, Arnold R

机构信息

Department of Internal Medicine III (Hematology and Oncology), University of Ulm, Germany.

出版信息

Transplant Proc. 1994 Dec;26(6):3114-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).用抗白细胞介素-2受体抗体（BT563）治疗异基因骨髓移植后类固醇难治性急性移植物抗宿主病。

Transplant Proc. 1994 Dec;26(6):3114-6.

2

Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.用甲泼尼龙和环孢素治疗急性移植物抗宿主病，联合或不联合抗白细胞介素-2受体单克隆抗体。一项多中心III期研究。

Transplantation. 1995 Nov 15;60(9):939-42.

3

Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.

Bone Marrow Transplant. 1994 May;13(5):563-9.

4

Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor.用抗白细胞介素-2受体的鼠单克隆抗体治疗急性移植物抗宿主病。

Bone Marrow Transplant. 1991;7 Suppl 2:151.

5

Use of an anti-interleukine 2 receptor monoclonal antibody for GvHD prophylaxis in unrelated bone marrow transplantation. GEGMO Group.抗白细胞介素2受体单克隆抗体在非亲缘骨髓移植中预防移植物抗宿主病的应用。GEGMO研究组

Bone Marrow Transplant. 1993;11 Suppl 1:112-3.

6

Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.单克隆抗TNFα抗体用于治疗对皮质类固醇和抗IL-2R抗体均耐药的急性移植物抗宿主病。

Bone Marrow Transplant. 1991;7 Suppl 2:149.

7

A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.一项关于抗白细胞介素-2受体抗体用于肝移植后免疫抑制诱导治疗的随机、安慰剂对照试验。

Clin Transplant. 1998 Aug;12(4):303-12.

8

Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).

Bone Marrow Transplant. 1991;7 Suppl 2:150.

9

Prophylaxis of graft-versus-host disease in identical sibling donor bone marrow transplant by anti-IL-2 receptor monoclonal antibody LO-Tact-1.抗白细胞介素-2受体单克隆抗体LO-Tact-1对同基因同胞供体骨髓移植中移植物抗宿主病的预防作用

Bone Marrow Transplant. 1995 Oct;16(4):577-81.

10

Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation.在匹配和不匹配的骨髓移植中，将单克隆抗体用于体内作为急性移植物抗宿主病的治疗策略。

Transplant Proc. 1991 Feb;23(1 Pt 2):1692-4.

引用本文的文献

1

Secondary treatment of acute graft-versus-host disease: a critical review.急性移植物抗宿主病的二级治疗：批判性评价。

Biol Blood Marrow Transplant. 2012 Jul;18(7):982-8. doi: 10.1016/j.bbmt.2012.04.006. Epub 2012 Apr 14.

2

Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.英欧联单抗的暴露-效应群体模型，英欧联单抗是一种用于急性移植物抗宿主病一线治疗的单克隆抗体。

Clin Pharmacokinet. 2007;46(5):417-32. doi: 10.2165/00003088-200746050-00004.